Stifel Initiates Coverage On Immunome with Hold Rating, Announces Price Target of $24
Benzinga Newsdesk 1 month ago
Analyst RatingsNewsInitiationPrice Target
Stifel analyst Dara Azar initiates coverage on Immunome (NASDAQ:IMNM) with a Hold rating and announces Price Target of $24.
Stifel analyst Dara Azar initiates coverage on Immunome (NASDAQ:IMNM) with a Hold rating and announces Price Target of $24.